Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy.

Neurodegenerative diseases like Alzheimer's and Parkinson's involve progressive brain cell damage that affects memory, movement, and daily functioning. Scientists are discovering that certain natural plant compounds called polyphenols—found in foods like green tea, turmeric, and grapes—may help protect the brain through a mechanism called epigenetics, which controls how our genes work without changing the DNA itself. This review examined how polyphenols such as curcumin (from turmeric), resveratrol (from grapes), and EGCG (from green tea) affect brain health. Researchers found these compounds can reduce brain inflammation, improve energy production in brain cells, help damaged neurons regenerate, and regulate genes involved in brain protection. They work by modifying enzymes that control gene activity, influencing DNA methylation, histone modifications, and RNA regulation—all processes that affect how brain cells function and survive. However, these compounds face challenges when taken orally because they're poorly absorbed, quickly broken down by the body, and don't efficiently reach the brain. Scientists are developing new delivery methods using nanotechnology and modified versions of these compounds to improve their effectiveness. While this research is promising, most studies have been conducted in laboratories or animal models, and more human clinical trials are needed. For patients with neurodegenerative conditions, combining these dietary approaches with proven therapies like acupuncture may offer complementary benefits for managing symptoms and supporting overall brain health. If you're considering acupuncture for neurological concerns, seek a licensed acupuncturist with experience treating neurodegenerative conditions.

This comprehensive review examines the neuroprotective mechanisms of polyphenolic compounds in neurodegenerative diseases through epigenetic regulation. The authors analyzed existing literature on polyphenols including curcumin, resveratrol, and epigallocatechin gallate (EGCG), focusing on their modulation of DNA methyltransferase activity, histone acetylation, and non-coding RNA expression. Key mechanisms identified include reduction of neuroinflammation, enhancement of mitochondrial function, promotion of neuroregeneration, and regulation of neurotrophic factors and synapse-related genes. The review highlights significant therapeutic limitations including low oral bioavailability, rapid metabolism, and insufficient brain-targeting capacity. Emerging solutions discussed include nano-delivery systems, prodrug design, and multi-omics approaches for personalized treatment strategies. Clinical takeaway: Polyphenols demonstrate multi-target neuroprotective effects via epigenetic pathways, offering potential adjunctive therapeutic value in neurodegenerative disease management. However, current evidence is primarily preclinical, necessitating further human trials and bioavailability optimization before clinical implementation. Practitioners should consider these compounds as part of integrative treatment protocols while awaiting translational research outcomes.